缓解转移性细胞癌骨事件的风险
1Division of Hematology-Oncology, University of California-San Diego School of Medicine, La Jolla, CA, USA.
European urology focus
|April 25, 2025
概括
转移性细胞癌 (mRCC) 的骨转移会导致严重的并发症. 综合免疫疗法,向疗法和局部治疗的多学科护理改善了这些患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 腎臟病學 (nephrology) 是一種醫學.
- 骨生物学 骨生物学
背景情况:
- 骨转移是转移性细胞癌 (mRCC) 的常见并发症,导致显著的发病率和降低的生存率.
- 管理需要全面的方法,包括整体治疗,局部干预和支持性护理.
研究的目的:
- 审查目前在mRCC中管理骨转移的现状.
- 突出新型治疗策略的有效性和个性化患者护理的重要性.
主要方法:
- 关于mRCC骨转移的当前文献的审查.
- 对包括免疫检查点抑制剂 (ICI) 和VEGF向剂在内的全身疗法的分析.
- 对局部疗法 (手术,放射治疗) 和骨修饰剂的评估.
主要成果:
- 基于ICI的组合显示在骨参与的mRCC中具有显著的疗效.
- 骨修饰剂具有好处,但在RCC骨病理学方面可能存在局限性.
- 局部疗法对于控制症状至关重要,特别是在寡头转移性疾病中.
结论:
- 多学科,个性化的策略是管理mRCC骨转移的关键.
- 优化治疗可以最大限度地减少治疗中断,并解决骨并发症.
- 改善患者的治疗结果需要针对骨发病率量身定制的干预措施.
更多相关视频
06:38A Syngeneic Mouse Model of Metastatic Renal Cell Carcinoma for Quantitative and Longitudinal Assessment of Preclinical Therapies
Published on: April 12, 2017
07:50Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
Published on: May 25, 2018
相关概念视频
Metastasis
5.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.4K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
305
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
305
